Oregon Health and Science University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Determinants of Surgical Outcomes in Chronic Sinusitis

Completed

Conditions: Chronic Rhinosinusitis

First Posted Date: 2008-11-27

Last Posted Date: 2010-05-20

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 516

Registration Number: NCT00799097

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Melatonin Studies of Totally Blind Children

Not Applicable

Terminated

Conditions: Sleep Disorder
Blindness

Interventions: Drug: Melatonin

First Posted Date: 2008-11-21

Last Posted Date: 2019-11-27

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 13

Registration Number: NCT00795236

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease

Not Applicable

Terminated

Conditions: Parkinson's Disease

Interventions: Drug: Amantadine 300 mg
Drug: Sugar Pill
Drug: Topiramate

First Posted Date: 2008-11-20

Last Posted Date: 2018-02-01

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 3

Registration Number: NCT00794313

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Study of Pathways Curriculum for Use With WPD

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Pathways

First Posted Date: 2008-11-11

Last Posted Date: 2012-10-17

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 80

Registration Number: NCT00788814

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.

Not Applicable

Completed

Conditions: Post-Traumatic Stress Disorders

Interventions: Behavioral: Slow Breathing
Behavioral: Sitting Quietly
Behavioral: Meditation
Behavioral: Meditation and slow breathing

First Posted Date: 2008-10-24

Last Posted Date: 2015-07-13

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 102

Registration Number: NCT00778960

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

Evaluation of Surgical Treatment on Pain and Disability for Chronic, Non-healing Rib Fracture

Phase 4

Completed

Conditions: Rib Fracture

Interventions: Device: Resection with or without plate fixation

First Posted Date: 2008-10-17

Last Posted Date: 2013-03-22

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 34

Registration Number: NCT00774618

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

Phase 2

Withdrawn

Conditions: Parkinson's Disease

Interventions: Drug: Apomorphine

First Posted Date: 2008-09-25

Last Posted Date: 2018-11-02

Lead Sponsor: Oregon Health and Science University

Registration Number: NCT00758368

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

American Ginseng Treatment for Multiple Sclerosis Related Fatigue

Phase 2

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: American ginseng extract HT-1001
Drug: placebo

First Posted Date: 2008-09-18

Last Posted Date: 2012-01-24

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 56

Registration Number: NCT00754832

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Study of Ultrasound of the Eye for Children With Suspected Shunt Failure

Completed

Conditions: Hydrocephalus

Interventions: Device: Ocular Ultrasound

First Posted Date: 2008-08-28

Last Posted Date: 2012-10-15

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 36

Registration Number: NCT00743457

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)

Phase 4

Conditions: HDL Cholesterol

Interventions: Drug: Simvastatin
Drug: Atorvastatin 80 mg

First Posted Date: 2008-08-15

Last Posted Date: 2011-07-22

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 80

Registration Number: NCT00736463

Locations: 🇺🇸
OHSU Hospital, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy